Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 256 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22094100G>A |
| Variant | c.849+1G>A |
| Variant Start Position | 849 |
| Location | Intron 7 |
| Amino Acid Change | p.? |
| ACMG Call | Pathogenic |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Pathogenic | Effect Type | Splice donor |
| Variant Type | Splicing |
| PMID | 16636593, 12414858, 24857004, 20578943, 34806794 |
| Article Count | 5 |
| Times Observed | 3-5 |
| Clinical Phenotype | - |
| ACMG Categories | - |
| ACMG Explanations | - |
| Variant in Clinvar | Yes |
| ClinVar Classification | Pathogenic |
| Categories In Literature | - |
| No Contrary Evidence Found | No |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | - |
| Other Alleles | - |
| Note | nan |
| Warnings | - |